Abstract:Diabetes has been the largest global epidemic in 21st century, and the cost for diabetes and its complications is about 12% of global health expenditure. Diabetic neuropathy is the most common complication of diabetes, affecting up to 50% of patients over the course of their disease. Among them, 30‐50% develop neuropathic pain, which has typical symptoms that originate from toes and progress to foot ulcer and seriously influences the quality of life. The pathogenesis of diabetic neuropathic pain (DNP) is complicated and incompletely understood and there is no effective treatment except supportive treatment. Long non‐coding RNAs (lncRNAs), a class of non‐coding RNAs exceeding 200 nucleotides in length, have been shown to play key roles in fundamental cellular processes, which are considered to be potential targets for treatment. Recent researches indicate that lncRNA is involved in the pathogenesis of DNP. Certain over‐expressed lncRNAs can enhance the purinergic receptor‐mediated neuropathic pain in peripheral ganglia and inflammatory cytokines are released due to receptors activated by ATP. In recent years, our laboratory also has been exploring the relationship and pathogenesis between lncRNAs and DNP. In this review, we put stress on the recent progress of functional lncRNAs associated with DNP and investigate their roles related to respective receptors.This article is protected by copyright. All rights reserved.

Long non coding RNAs involved in MAPK pathway mechanism mediates diabetic neuropathic pain